References in this report to "we," "Actelis," "us," "our," or the "Company"
refer to Actelis Networks, Inc. and its wholly owned subsidiary. References to
our "management" or our "management team" refer to our officers and directors.
You should read the following discussion of our historical performance,
financial condition and future prospects in conjunction with the management's
discussion and analysis of financial conditions and results of operations and
the audited consolidated financial statements included in our prospectus dated
May 12, 2022, filed with the Securities and Exchange Commission (the "SEC") on
May 16, 2022 pursuant to Rule 424(b)(4) of the Securities Act of 1933, as
amended (the "Securities Act") (referred to herein as the "Prospectus"). The
following discussion and analysis of our financial condition and results of
operations should also be read in conjunction with the condensed consolidated
financial statements (including the notes thereto) contained elsewhere in this
report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risk and uncertainties.
For further information on items that could impact our future operating
performance or financial condition, see the sections titled "Risk Factors"
included in the Prospectus and the Special Note Regarding Forward Looking
Statements above.



Overview



Actelis is a networking solutions company with a mission to enable cyber secure,
rapid deployment networking for all for wide-area Internet of Things, or IoT,
projects, enabling applications in Smart Cities, Smart Campuses, airports,
military bases, Smart Roads, Smart Rail, and utilities.



Our patented hybrid fiber-copper networking solutions deliver excellent
communication over fiber to locations that may be easy to reach with new fiber.
However, for locations that are difficult to reach with fiber, we can upgrade
existing copper lines, to deliver cyber-hardened, high-speed connectivity
without needing to replace the existing copper infrastructure with new fiber. We
believe that such hybrid fiber-copper networking solution has distinct
advantages in most real-life installations, providing significant budget savings
and accelerating deployment of modern IoT networks. We believe that our
solutions can provide connectivity over fiber or copper up to multi-Gigabit
communication, while supporting Gigabit-Grade reliability and quality.



When high-speed, long reach, high reliability and secure connectivity is
required, network operators usually resort to using wireline communication over
physical communication lines rather than wireless communication that is more
limited in performance, reliability and security. However, wireline
communication infrastructure is costly, and often accounts for more than 50% of
total cost of ownership and time to deploy wide-area IoT projects.



Typically, providing new fiber connectivity to hard-to-reach locations is costly
and time-consuming, often requiring permits for boring, trenching, and
right-of-way. Connecting such hard-to-reach locations, may cause significant
delays and budget overruns in IoT projects. Our solutions aim to solve these
challenges.


By alleviating difficult challenges in connectivity, we believe that Actelis' solutions are making a significant difference by effectively accelerating deployment of IoT projects, and making IoT projects more affordable and predictable to plan and budget.





Our solutions also offer end-to-end network security to protect critical IoT
data, utilizing a powerful combination of coding and encryption technologies,
applied as required on both new and existing infrastructure within the
hybrid-fiber-copper network. Our solutions have been tested for performance and
security by the U.S. Department of Defense, or the U.S. DoD, laboratories, and
approved for deployment with the U.S. Federal Government.



                                       1





As of September 30, 2022, we had more than 300 customers, including cities, road
and rail authorities, utilities and military organizations. We experienced an
average annual sales growth in our IoT business of more than 20% each year from
2018 through 2021 in booking of orders from customers in the IoT market.



Since our inception, our business was focused on serving telecommunication
service providers, also known as Telcos, providing connectivity for enterprises
and residential customers. Our products and solutions have been deployed with
more than 100 telecommunication service providers worldwide, in enterprise,
residential and mobile base station connectivity applications. In recent years,
as we have further developed our technology and rolled out additional products,
we turned our focus on serving the wide-area IoT markets. Our operations are
focused on our fast-growing IoT business, while maintaining our commitment

to
our existing Telco customers.



We currently have one outstanding loan with Migdalor Business Investments Fund,
or Migdalor, which is secured by all our assets. As of September 30, 2022, the
amount outstanding under the loan is $5.00 million (based on the NIS/USD
exchange rate as of such date) (the "Migdalor Loan"). If we cannot generate
sufficient cash flow from operations to service our debt, we may need to further
refinance our debt, dispose of assets or issue equity to obtain necessary funds.
We expect to continue repaying the principal and interest of the Migdalor Loan
from our operating cash flow.



Initial Public Offering



On May 17, 2022, we closed our IPO of common shares, in which we sold a total of
4,212,500 shares of common stock at $4 per share, including 462,500 shares
pursuant to the partial exercise of the underwriters' over-allotment option, for
total net proceeds of $15.4 million, which, after deducting underwriting
discounts and commissions of $1.4 million before additionally paid offering
expenses of approximately $1.0 million amounted to proceeds available to the
Company of $14.4 million.



Upon the closing of our IPO, all outstanding shares of our redeemable
convertible preferred stock automatically converted into 7,731,083 shares of
common stock on a one-for-one basis. For additional information, see Note 1(d)
to our Condensed Consolidated Financial Statements.



Impact of COVID-19 Pandemic



There continues to be widespread impact from the COVID-19 pandemic.  Beginning
in the first quarter of 2021, there has been a trend in many parts of the world
of increasing availability and administration of vaccines against COVID-19, as
well as an easing of restrictions on social, business, travel and government
activities and functions. Although infection rates and regulations have
decreased globally, we continue to experience material residual impacts
resulting from the pandemic, including inflationary impact on our cost structure
and our operating expenses, specifically increases in costs for logistics and
supply chains, heavy purchase price variance of electronic components, as well
as from various operating vendors we use in our ongoing business. This
inflationary environment contributes to recent increases in interest rates, as
well as in the strengthening of the U.S. dollar against foreign currencies,
which is affecting our business partners, where they sell local currency to the
end-user of our products and services. Furthermore, this inflationary impact has
affected us by requiring certain employment and compensation adjustments
necessary to remain a competitive employer.



                                       2





Results of Operations



The table below provides our results of operations for the periods indicated.



                                                Three months ended               Nine months ended
                                                   September 30                     September 30
                                               2022             2021            2022             2021
                                              (dollars in thousands)           (dollars in thousands)
Revenues                                           1,348          1,422            6,297           5,995
Cost of revenues                                     813            896            3,258           3,002
Gross profit                                         535            526            3,039           2,993

Research and development expenses, net               723            552            2,049           1,818
Sales and marketing, net                             790            627            2,357           1,576
General and administrative, net                    1,028            255            2,730             906
Operating loss                                    (2,006 )         (908 )         (4,097 )        (1,307 )
Financial expenses, net                             (201 )         (279 )         (4,403 )          (592 )
Net Comprehensive Loss for the period             (2,207 )       (1,187 )  

      (8,500 )        (1,899 )



Three and Nine Months Ended September 30, 2022 Compared to Three and Nine Months Ended September 30, 2021





Revenues


Our revenues for the three months ended September 30, 2022 amounted to $1.3 million, compared to $1.4 million for the three months ended September 30, 2021. The decrease is primarily driven by logistical delays in customer shipments.

Our revenues for the nine months ended September 30, 2022 amounted to $6.3 million, compared to $6.0 million for the nine months ended September 30, 2021. The increase from the corresponding period was primarily attributable to an increase of $650,000 of revenues generated from Europe, the Middle East and Africa, offset by a decrease of $348,000 in revenues generated from North America and Asia Pacific.





Cost of Revenues



Our cost of revenues for the three months ended September 30, 2022, amounted to
$0.8 million compared to $0.9 million for the three months ended September

30,
2021.



Our cost of revenues for the nine months ended September 30, 2022, amounted to
$3.3 million compared to $3.0 million for the nine months ended September 30,
2021. The increase from the corresponding period was mainly due to the increase
in revenues, as well as a change in the product mix and an increase in purchase
price variance of the cost of components and manufacturing driven by supply
shortages and shipment costs.



Research and Development Expenses


Our research and development expenses for the three months ended September 30,
2022 amounted to $0.7 million compared to $0.6 million for the three months
ended September 30, 2021. The increase was mainly due to the acceleration of
investments, primarily an increase in payroll expense in the amount of 131,000,
in research and development.



Our research and development expenses for the nine months ended September 30,
2022 amounted to $2.0 million compared to $1.8 million for the nine months ended
September 30, 2021. The increase was mainly due to the acceleration of
investments, primarily an increase in payroll expenses in the amount of
$230,000.



Sales and Marketing Expenses



Our sales and marketing expenses for the three months ended September 30, 2022
amounted to $0.8 million compared to $0.6 for the three months ended September
30, 2021. The increase from the corresponding period was mainly associated with
increased investments in sales and marketing, specifically in payroll expenses
in the amount of $97,000, mainly due to hiring of sales and marketing employees
and increase in travel expenses in the amount of $66,000, offset by a decrease
in professional services in the amount of $42,000.



                                       3





Our sales and marketing expenses for the nine months ended September 30, 2022
amounted to $2.4 million compared to $1.6 for the nine months ended September
30, 2021. The increase in comparison with the corresponding period was mainly
associated with increased sales compensation due to higher revenue of $192,000,
increased investments in sales and marketing, specifically in payroll expenses
in the amount of $382,000, mainly due to hiring of sales and marketing
employees, increase in other professional services in the amount of $41,000 and
increase in travel expenses in the amount of $138,000.



General and Administrative Expenses





Our general and administrative expenses for the three months ended September 30,
2022 amounted to $1.0 million compared to $0.3 million for the three months
ended September 30, 2021. The increase was mainly due to payroll and
professional services expenses attributed to being a public company following
our IPO completed in May 2022.



Our general and administrative expenses for the nine months ended September 30,
2022 amounted to $2.7 million compared to $0.9 million for the nine months ended
September 30, 2021. The increase was mainly due to payroll and professional
services expenses attributed to the work on the IPO in the amount of $1.0
million, completed in May 2022, as well as to being a public company.



Operating Loss



Our operating loss for the three months ended September 30, 2022, was $2.0
million, compared to an operating income of $0.9 million for the three months
ended September 30, 2021. The increase was mainly due higher expenses associated
primarily with investment in sales and marketing and expenses attributed to
being a public company.



Our operating loss for the nine months ended September 30, 2022, was $4.1
million, compared to an operating loss of $1.3 million for the nine months ended
September 30, 2021. The increase was mainly due to a delay in supply, due to
shortages, as well as higher expenses associated primarily with investment in
sales and marketing and expenses attributed to the IPO completed in May 2022 and
being a public company.



Financial Expenses, Net



Our financial expense, net for the three months ended September 30, 2022, was
$0.2 million compared to $0.3 million for the three months ended September 30,
2021. The decrease is attributed mostly to exchange rate differences.



Our financial expense, net for the nine months ended September 30, 2022 was $4.4
million compared to $0.6 million for the nine months ended September 30, 2021.
During the nine months ended September 30, 2022, we incurred financial expenses
mainly due to increases in fair value of various financial instruments, such as
convertible loan, note and warrants in the amount of $4.5 million up until the
IPO when such instruments converted to equity, and had income in the amount of
$0.7 million, from exchange rate differences. Since all convertible loans and
nearly all warrants we had outstanding converted to equity in connection with
the IPO, we do not expect additional material financial expenses going forward
for these loans and warrants compared to those we incurred in 2020, 2021 and the
first two quarters of 2022.



Net Loss



Our net loss for the three months ended September 30, 2022 was $2.2 million,
compared to net loss of $1.2 million for the three months ended September 30,
2021. The increase was primarily due to the increase in operating expenses
mainly due to investment in sales and marketing, as well as expenses attributed
to being a public company.



                                       4





Our net loss for the nine months ended September 30, 2022 was $8.5 million,
compared to net loss of $1.9 million for the nine months ended September 30,
2021. The increase was primarily due to the increase in financial expenses,
resulting from the increases in fair value of various financial instruments, as
well as an increase in operating expenses mainly due to investment in sales and
marketing, as well as expenses attributed to our IPO in May 2022 and being

a
public company.



Non-GAAP Financial Measures



                                              Three months         Three months          Nine months          Nine months
                                                  Ended                Ended                Ended                Ended
                                              September 30,       

September 30, September 30, September 30, (U.S. dollars in thousands)

                       2022                 2021                 2022                 2021
Revenues                                     $         1,348      $         1,422      $         6,297      $         5,995
GAAP net loss                                         (2,207 )             (1,187 )             (8,500 )             (1,899 )
Interest Expense                                         201                  279                4,403                  592
Tax Expense                                               28                    6                  102                   69

Fixed asset depreciation expense                           9                    7                   29                   31
Stock based compensation                                  13                    8                   41                   28
Research and development, capitalization                 143                  119                  423                  472
Other one-time costs and expenses                        115                    -                  916                    -
Non-GAAP Adjusted EBITDA                              (1,698 )               (768 )             (2,586 )               (707 )
GAAP net loss margin                                 (163.72 )%            (83.47 )%           (134.98 )%            (31.67 )%
Adjusted EBITDA margin                               (125.96 )%           

(54.01 )%            (41.07 )%            (11.79 )%



Use of Non-GAAP Financial Information





Non-GAAP Adjusted EBITDA, Adjusted EBITDA margin, and backlog of customer open
orders are Non-GAAP financial measures. In addition to reporting financial
results in accordance with GAAP, we provide Non-GAAP supplemental operating
results adjusted for certain items, including: financial expenses, which are
interest, financial instrument fair value adjustments, exchange rate differences
of assets and liabilities, stock based compensation expenses, depreciation and
amortization expense, tax expense, and impact of development expenses ahead of
product launch. We adjust for the items listed above and show non-GAAP financial
measures in all periods presented, unless the impact is clearly immaterial to
our financial statements. When we calculate the tax effect of the adjustments,
we include all current and deferred income tax expense commensurate with the
adjusted measure of pre-tax profitability.



We utilize the adjusted results to review our ongoing operations without the
effect of these adjustments but not for comparison to budgeted operating
results. We reference measures of performance that cannot yet be reflected in
our financial results such as backlog of customer open orders. We believe the
supplemental adjusted results are useful to investors because they help them
compare our results to previous periods and provide important insights into
underlying trends in the business and how management oversees and optimizes our
business operations on a day-to-day basis. We exclude the costs in calculating
adjusted results to allow us and investors to evaluate the performance of the
business based upon its expected ongoing operating structure. We believe the
adjusted measures, accompanied by the disclosure of the costs of these programs,
provides valuable insight to our financial performance. Adjusted results should
be considered only in conjunction with results reported according to GAAP.




                                              For the three months ended            For the nine months ended
                                                     September 30                          September 30

(U.S. dollars in thousands)                     2022                2021             2022                2021
Revenues                                   $        1,348        $    1,422      $      6,297        $      5,995

Non-GAAP Adjusted EBITDA                           (1,698 )            (768 )          (2,586 )              (707 )

As a percentage of revenues                       (125.96 )%         (54.01 )%         (41.07 )%           (11.79 )%




                                       5




Backlog of Customer Open Orders


Our backlog of customer open orders consists of product orders for which we have
received a customer purchase order, and which have not yet been shipped. Orders
are generally not subject to cancellation or rescheduling by the customer. We
believe the review of backlog of customer open orders together with revenues is
useful supplemental information to investors because it provides important
insights into underlying trends in the business and how management oversees and
optimizes our business operations on a day-to-day basis. As of September 30,
2022, our firm backlog of customer open orders was $3.9 million and as of
September 30, 2021, our firm backlog of customer open orders was $5.2 million.
In almost all cases, the backlog of customer open orders has been caused by the
current global delays in supply in electronic components. We expect the majority
of the backlog of customer open orders as of September 30, 2022 to be shipped
during 2022.



                                              For the three months ended            For the nine months ended
(U.S. dollars in thousands Revenues)                 September 30                         September 30
                                               2022                2021              2022               2021

Revenues                                   $       1,348       $       

1,422 $ 6,297 $ 5,995



Backlog of open Orders(1)                  $       3,917       $       5,153     $      3,917       $      5,153

(1) Presented as of September 30 for each year.

Liquidity and Capital Resources


Since our inception, we have financed our operations primarily through the sale
of equity securities, debt financing, convertible loans and
royalty-bearing grants that we received from the Israel Innovation Authority.
Our primary requirements for liquidity and capital are to finance working
capital, capital expenditures and general corporate purposes. Our principal
sources of liquidity following our IPO in May 2022 as discussed below under the
section titled "Initial Public Offering," are expected to be the net proceeds
from this offering as well as cash proceeds generated from our sales.



Our future capital requirements will be affected by many factors, including our
revenue growth, the timing and extent of investments to support such growth, the
expansion of sales and marketing activities, increases in general and
administrative costs, repayment of principal of our existing credit line,
working capital to support securing raw material supply and many other factors
as described under "Risk Factors."



To the extent additional funds are necessary to meet our long-term liquidity
needs as we continue to execute our business strategy, we anticipate that they
will be obtained through the incurrence of additional indebtedness, additional
equity financings or a combination of these potential sources of funds; however,
such financing may not be available on favorable terms, or at all. In
particular, the repercussions from the COVID 19 pandemic, as well as the war
between Russia and the Ukraine, has resulted in, and may continue to result in,
significant disruption of global financial markets, reducing our ability to
access capital. If we are unable to raise additional funds when desired, our
business, financial condition and results of operations could be adversely
affected.



For the nine months ended September 30, 2022, we have incurred substantial costs
and expenses as we continued to build our infrastructure and prepare for growth,
which included incurring legal, insurance and accounting fees in preparation for
both the IPO and being a public company thereafter.



Our revenues for the three months ended September 30, 2022 decreased by 5.2% and
our revenues for the nine months ended September 30, 2022 increased by 5.0%,
over revenues for the three and nine months ended September 30, 2021,
respectively, as we increased product and service delivery to our customers and
as we made some progress in resolving supply shortages. In addition, backlog of
customer open orders remained high, as of September 30, 2022, as we had a
balance of $3.9 million, compared to a balance of $5.1 million as of September
30, 2021, representing a decrease of 23.5%, driven by faster delivery of delayed
orders as we continued to overcome supply chain shortages.



                                       6





Cash Flows



The table below, for the periods indicated, provides selected cash flow
information:



                                              Nine Months         Nine Months
                                                 Ended               Ended
                                             September 30,       September 30,
(U.S. dollars in thousands)                      2022                2021

Net cash used in operating activities $ (5,776 ) $ (1,478 ) Net cash used in investing activities

                  (102 )                (6 )
Net cash provided by financing activities            16,028               1,878
Net change in cash                          $        10,150     $           394




As of September 30, 2022, we had cash, cash equivalents, and restricted cash of
$10.9 million compared to $0.8 million of cash, cash equivalents and restricted
cash as of December 31, 2021.



Cash used in operating activities amounted to $5.8 million for the nine months
ended September 30, 2022, compared to $1.5 for the nine months ended September
30, 2021. The increase in cash used in operating activities was mainly due to
increase in operating expenses, as well as expenses associated with our IPO and
from operating as a public company.



Net cash used in investing activities was $0.1 million for the nine months ended
September 30, 2022, compared to cash used in investing activities of $0 for the
nine months ended September 30, 2021. The increase from the corresponding period
was mainly due to change in short term deposits and purchasing of property

and
equipment.



Net cash provided by financing activities was $16.0 million for the nine months
ended September 30, 2022, compared to $1.9 million for the nine months ended
September 30, 2021. The cash flow from financing activities for the nine months
ended September 30, 2022, resulted from proceeds from the Company's IPO in the
amount of $15.4, net of underwriting discounts and commissions and other
offering costs of $1.0 million. In addition, the increase is related to the $2.2
million raised from the private placement first and second closings.



Initial Public Offering


On May 17, 2022, the Company completed its IPO. Net proceeds from the IPO totaled $15.4, net of underwriting discounts and commissions of $1.4. Additionally, the Company paid offering expenses of approximately $1.0 million, amounting to proceeds available to the Company of $14.4 million.





In connection with the IPO, the following transactions occurred in the second
quarter of 2022: (i) The redeemable convertible Series A and Series B Preferred
Stock were converted into an aggregate of 7,731,083 shares of common stock; (ii)
The convertible notes and convertible loan were converted into an aggregate of
2,538,257 shares of common stock, (iii) The outstanding warrants issued to
Migdalor and Mizrahi-Tefahot Bank were converted into an aggregate 797,567
shares of common stock, (iv) 1,783,773 of Non-Voting Common Stock were redeemed
by the Company at par value of $0.0001 per share  and (v) we incurred
approximately $1.0 million of IPO expenses. Additionally, 294,875 warrants to
purchase common stock were issued upon the IPO to the underwriters at a
conversion price of $5.00 per share.



We believe that as a result of the IPO, as can be seen in the financial
instrument restructuring that occurred in connection therewith as described
above, we currently have sufficient cash to meet our expected funding
requirements over the next twelve months. However, we have experienced, and we
continue to experience, negative operating margins and cash outflows from
operating activities. We may need to raise additional capital in the future to
expand our presence in the marketplace and achieve operating efficiencies, and
to accomplish our long-term business plan over the next several years. There can
be no assurance as to the availability or terms upon which such financing and
capital might be available.



                                       7




We do not have any material commitments for capital expenditures during the next twelve months.

We may need to raise additional capital, which may not be available on reasonable terms or at all. Additional capital would be used to accomplish the following:





  ? finance our current operating expenses;

  ? pursue growth opportunities;

  ? hire and retain qualified management and key employees;

  ? respond to competitive pressures;

  ? comply with regulatory requirements; and

  ? maintain compliance with applicable laws.




Current conditions in the capital markets are such that traditional sources of
capital may not be available to us when needed or may be available only on
unfavorable terms. Our ability to raise additional capital, if needed, will
depend on conditions in the capital markets, economic conditions, the impact of
the COVID-19 pandemic, the Russian invasion of Ukraine, and a number of other
factors, many of which are outside our control, and on our financial
performance. Accordingly, we cannot assure you that we will be able to
successfully raise additional capital at all or on terms that are acceptable to
us. If we cannot raise additional capital when needed, it may have a material
adverse effect on our business, results of operations and financial condition.



To the extent that we raise additional capital through the sale of equity or
convertible debt securities, the issuance of such securities could result in
substantial dilution for our current stockholders. The terms of any securities
issued by us in future capital transactions may be more favorable to new
investors, and may include preferences, superior voting rights and the issuance
of warrants or other derivative securities, which may have a further dilutive
effect on the holders of any of our securities then-outstanding. We may issue
additional shares of our common stock or securities convertible into or
exchangeable or exercisable for our common stock in connection with hiring or
retaining personnel, option or warrant exercises, future acquisitions or future
placements of our securities for capital-raising or other business purposes. The
issuance of additional securities, whether equity or debt, by us, or the
possibility of such issuance, may cause the market price of our common stock to
decline and existing stockholders may not agree with our financing plans or the
terms of such financings. In addition, we may incur substantial costs in
pursuing future capital financing, including investment banking fees, legal
fees, accounting fees, securities law compliance fees, printing and distribution
expenses and other costs. We may also be required to recognize non-cash expenses
in connection with certain securities we issue, such as convertible notes and
warrants, which may adversely impact our financial condition. Furthermore, any
additional debt or equity financing that we may need may not be available on
terms favorable to us, or at all. If we are unable to obtain such additional
financing on a timely basis, we may have to curtail our development activities
and growth plans and/or be forced to sell assets, perhaps on unfavorable terms,
or we may have to cease our operations, which would have a material adverse
effect on our business, results of operations and financial condition.



We have not entered into any transactions with unconsolidated entities in which
we have financial guarantees, subordinated retained interests, derivative
instruments or other contingent arrangements that expose us to material
continuing risks, contingent liabilities or any other obligations under a
variable interest in an unconsolidated entity that provides us with financing,
liquidity, market risk or credit risk support.



                                       8




Critical Accounting Policies and Estimates


Our condensed consolidated financial statements are prepared in accordance with
U.S. GAAP. The preparation of these condensed consolidated financial statements
requires management to make estimates, assumptions and judgments that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements, and the reported
amounts of revenue and expenses during the applicable periods. We evaluate our
estimates, assumptions and judgments on an ongoing basis. Our estimates,
assumptions and judgments are based on historical experience and various other
factors that we believe to be reasonable under the circumstances. Different
assumptions and judgments would change the estimates used in the preparation of
our condensed consolidated financial statements, which, in turn, could change
the results from those reported.



Our management's discussion and analysis of our financial condition and results
of operations is based on our financial statements, which we have prepared in
accordance with U.S. generally accepted accounting principles issued by the
Financial Accounting Standards Board, or FASB.



Our significant accounting policies include revenue from contracts with
customers which is more fully described in the notes to our condensed
consolidated financial statements appearing elsewhere in this Quarterly report
on Form 10-Q and annual financial statements for the year 2021 for a description
of our significant accounting policies. We believe that these accounting
policies discussed are critical to our financial results and to the
understanding of our past and future performance, as these policies relate to
the more significant areas involving management's estimates and assumptions. We
consider an accounting estimate to be critical if: (1) it requires us to make
assumptions because information was not available at the time or it included
matters that were highly uncertain at the time we were making our estimate; and
(2) changes in the estimate could have a material impact on our financial
condition or results of operations.

© Edgar Online, source Glimpses